Economic assessment of capecitabinexisplatin versus 5-FU/Cisplatin regimens in adjuvant treatment of advanced gastric cancer in Spain

被引：0
|
作者：
Darba, J. [1 ]
Restovic, G. [1 ]
De Arellano, Ramirez A. [1 ]
机构：
[1] Univ Barcelona, E-08007 Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [41] New Perspectives in the Treatment of Advanced Gastric Cancer: S-1 as a Novel Oral 5-FU Therapy in Combination with Cisplatin
    Mahlberg, Rolf
    Lorenzen, Sylvie
    Thuss-Patience, Peter
    Heinemann, Volker
    Pfeiffer, Per
    Mohler, Markus
    [J]. CHEMOTHERAPY, 2017, 62 (01) : 62 - 70
  • [42] SALVAGE TREATMENT WITH CISPLATIN (CDDP) AND 5-FLUOROURACIL (5-FU) IN ADVANCED BREAST-CANCER PATIENTS
    PRONZATO, P
    AMOROSO, D
    BERTELLI, G
    LIONETTO, R
    ARDIZZONI, A
    CONTE, PF
    ROSSO, R
    GALLOTTI, P
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1987, 10 (01) : 108 - 108
  • [43] The clinical studies of weekly Taxol plus Cisplatin and continuous infusion of 5-FU in patients with advanced gastric cancer
    Jia, Chen
    Ling, Hang F.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 234 - 234
  • [44] Predictive value of genomic polymorphisms on clinical outcome to cisplatin/5-FU chemotherapy in patients with advanced gastric cancer
    Goekkurt, Eray
    Wittmer, Corinna
    Wolschke, Christine
    Stueber, Christian
    Hoehn, Stephan
    Laack, Eckart
    Erbersdobler, Andreas
    Hossfeld, Dieter K.
    Stoehlmacher, Jan
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 237 - 238
  • [45] Neoadjuvant and adjuvant radiochemotherapy of pancreatic cancer with 5-FU, cisplatin and interferon-alpha
    Schmidberger, H
    Horstmann, O
    Nitsche, M
    Hermann, R
    Becker, H
    Hess, CF
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 : 28 - 28
  • [46] A pilot trial of 5-FU, leucovorin, and cisplatin with or without Adriamycin in advanced cancer
    Vaughn, DJ
    Meropol, NJ
    Armstead, B
    Haller, DG
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (03): : 241 - 244
  • [47] Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancer
    Pera, M.
    Gallego, R.
    Montagut, C.
    Martin-Richard, M.
    Iglesias, M.
    Conill, C.
    Reig, A.
    Balague, C.
    Petriz, L.
    Momblan, D.
    Bellmunt, J.
    Maurel, J.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 (03) : 664 - +
  • [48] 5-FU INFUSION AND CYCLOPHOSPHAMIDE IN TREATMENT OF ADVANCED OVARIAN CANCER
    IZBICKI, RM
    BAKER, LH
    SAMSON, MK
    MCDONALD, B
    VAITKEVICIUS, VK
    [J]. CANCER TREATMENT REPORTS, 1977, 61 (08): : 1573 - 1575
  • [49] Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer
    Bleiberg, H
    Conroy, T
    Paillot, B
    Lacave, AJ
    Blijham, G
    Jacob, JH
    Bedenne, L
    Namer, M
    DeBesi, P
    Gay, F
    Collette, L
    Sahmoud, T
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (08) : 1216 - 1220
  • [50] SUMMARY OF THE AIO 7/90 PROTOCOL - RANDOMIZED PHASE-222 STUDY WITH ELF (ETOPOSIDE/5-FU/LEUCOVORIN) VERSUS 5-FU INFUSION/CISPLATIN VERSUS FAMTX (METHOTREXATE/5-FU/ADRIAMYCIN) IN ADVANCED STOMACH-CANCER
    WILS, J
    WILKE, H
    ROUGIER, P
    PREUSSER, P
    LACAVE, A
    [J]. ONKOLOGIE, 1992, 15 (01): : 71 - 72
12345